ISRCTN ISRCTN09810203
DOI https://doi.org/10.1186/ISRCTN09810203
Protocol serial number N/A
Sponsor Carige Foundation (Fondazione Carige [Cassa di Risparmio di Genova e Imperia]) (Italy)
Funder Carige Foundation (Fondazione Carige [Cassa di Risparmio di Genova e Imperia]) (Italy)
Submission date
16/01/2010
Registration date
18/02/2010
Last edited
18/02/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Giacomo Deferrari
Scientific

Rettorato Università di Genova
Via Balbi 5
Genova
16100
Italy

Study information

Primary study designObservational
Study designRetrospective analysis and observational prospective study
Secondary study designOther
Study type Participant information sheet
Scientific titleChronic kidney disease and cardiovascular risk in primary care
Study acronymGENOA
Study objectivesTo analyse the influence of estimated glomerular filtration rate and proteinuria on survival, free of cardiovascular and renal events, and to test the accuracy of calculators including renal function indices in predicting cardiovascular outcomes of primary care patients
Ethics approval(s)Trial not requiring ethical approval as study design is completely adherent to the recommendations issued by the local ethical committee of Azienda Ospedaliera S. Martino (Genova, Italy) and in accordance to the guidelines issued by the Helsinki declaration.
Health condition(s) or problem(s) studiedChronic kidney disease
InterventionData will be extracted from the Health Search Database (HSD). The HSD was set up in 1998 and managed by the Italian College of GPs. The HSD contains information provided by more than 650 Italian GPs, and includes data on more than 1,000,000 individuals.
Demographic, clinical and laboratory data, namely age, sex, body weight, height, blood pressure (BP) values, serum lipids, and serum creatinine will be evaluated for each patient. The presence of diabetes, smoking habits, and the occurrence of previous major cardiovascular events, such as stroke, angina and myocardial infarction will also be extracted from the HSD for each patient. The number and classes of antihypertensive medications will also be retrieved for each patient. Global cardiovascular risk will be calculated for each subject by various calculators including the Framingham, the Heart Score, and the INDANA. Follow-up will be about 5-7 years.
Intervention typeOther
Primary outcome measure(s)

Death (any cause)

Key secondary outcome measure(s)

1. Survival free of cardiovascular events
2. Survival free of renal event
3. Accuracy of different risk calculators in predicting outcome

Completion date31/12/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration70000
Key inclusion criteriaItalian general population followed in primary care
Key exclusion criteriaSubjects in whom serum creatinine measurement is not available
Date of first enrolment01/01/2003
Date of final enrolment31/12/2011

Locations

Countries of recruitment

  • Italy

Study participating centre

Rettorato Università di Genova
Genova
16100
Italy

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes